{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:53:41Z","timestamp":1793278421168,"version":"4.5.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.thromres.2021.05.018","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T03:43:08Z","timestamp":1623210188000},"page":"40-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"special_numbering":"C","title":["Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia"],"prefix":"10.1016","volume":"204","author":[{"given":"Theodore E.","family":"Warkentin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Greinacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.thromres.2021.05.018_bb0005","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.amjmed.2008.03.012","article-title":"A spontaneous prothrombotic disorder resembling heparin-induced thrombocytopenia","volume":"121","author":"Warkentin","year":"2008","journal-title":"Am. J. Med."},{"issue":"9","key":"10.1016\/j.thromres.2021.05.018_bb0010","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1538-7836.2008.03040.x","article-title":"Fatal heparin-induced thrombocytopenia (HIT) during warfarin thromboprophylaxis following orthopedic surgery: another example of 'spontaneous' HIT?","volume":"6","author":"Jay","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2021.05.018_bb0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1538-7836.2008.03263.x","article-title":"Heparin-induced thrombocytopenia (HIT) during postoperative warfarin thromboprophylaxis: a second example of postorthopedic surgery \u2018spontaneous\u2019 HIT?","volume":"7","author":"Pruthi","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MBC.0b013e328340ff11","article-title":"A patient with \u2018spontaneous\u2019 heparin-induced thrombocytopenia and thrombosis after undergoing knee replacement","volume":"22","author":"Mallik","year":"2011","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/09537104.2011.650245","article-title":"Rapid-onset heparin-induced thrombocytopenia with previous heparin exposure","volume":"23","author":"Olah","year":"2012","journal-title":"Platelets."},{"issue":"4","key":"10.1016\/j.thromres.2021.05.018_bb0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1160\/TH11-12-0825","article-title":"Rapid onset heparin-induced thrombocytopenia (HIT) without history of heparin exposure: a new case of so-called \u2018spontaneous\u2019 HIT","volume":"107","author":"Perrin","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2021.05.018_bb0035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1160\/TH12-11-0865","article-title":"Adrenal haemorrhage due to heparin-induced thrombocytopenia","volume":"109","author":"Ketha","year":"2013","journal-title":"Thromb. Haemost."},{"issue":"23","key":"10.1016\/j.thromres.2021.05.018_bb0040","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1182\/blood-2014-01-549741","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder","volume":"123","author":"Warkentin","year":"2014","journal-title":"Blood."},{"issue":"23","key":"10.1016\/j.thromres.2021.05.018_bb0045","first-page":"3536","article-title":"Me or not me?","volume":"123","author":"Greinacher","year":"2014","journal-title":"The danger of spontaneity, Blood"},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/09537104.2014.979338","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: atypical clinical features with heparin-dependent platelet activating antibodies","volume":"26","author":"Okata","year":"2015","journal-title":"Platelets."},{"issue":"5","key":"10.1016\/j.thromres.2021.05.018_bb0055","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMc1414161","article-title":"Heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages","volume":"372","author":"Warkentin","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2021.05.018_bb0060","article-title":"Bilateral adrenal hemorrhage presenting with delayed adrenal crisis in a patient on rivaroxaban (Xaeralto) [sic]","volume":"36","author":"Machhadieh","year":"2015","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.thromres.2021.05.018_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.artd.2015.07.003","article-title":"Spontaneous heparin-induced thrombocytopenia presenting as bilateral adrenal hemorrhages and pulmonary embolism after total knee arthroplasty","volume":"1","author":"Elshoury","year":"2015","journal-title":"Arthroplast. Today."},{"key":"10.1016\/j.thromres.2021.05.018_bb0070","first-page":"4918623","article-title":"Spontaneous heparin-induced thrombocytopenia and venous thromboembolism following total knee arthroplasty","volume":"2017","author":"Baker","year":"2017","journal-title":"Case Rep. Hematol."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2021.05.018_bb0075","first-page":"1355","article-title":"Isolation of a monoclonal IgG kappa with functional autoantibody activity against platelet factor 4\/heparin from a patient with a monoclonal gammopathy of undetermined significance and clinically overt heparin thrombocytopenia [Conference Abstract]","volume":"1","author":"Faille","year":"2017","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0080","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/09537104.2017.1366973","article-title":"Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review","volume":"28","author":"Poudel","year":"2017","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2021.05.018_bb0085","series-title":"Spontaneous HIT Syndrome","volume":"5","author":"McCarthy","year":"2018"},{"issue":"3","key":"10.1016\/j.thromres.2021.05.018_bb0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/trf.15105","article-title":"Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia","volume":"59","author":"Irani","year":"2019","journal-title":"Transfusion."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0095","first-page":"e70","article-title":"Adrenal insufficiency from unilateral hemorrhage in a patient on rivaroxaban thromboprophylaxis","volume":"5","author":"Ly","year":"2019","journal-title":"AACE. Clin. Case Rep."},{"issue":"5","key":"10.1016\/j.thromres.2021.05.018_bb0100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/jth.14411","article-title":"High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome","volume":"17","author":"Mohanty","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.05.018_bb0105","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.12659\/AJCR.917780","article-title":"Rivaroxaban related bilateral adrenal hemorrhage: a rare complications of direct oral anticoagulants \u2013 a case reports","volume":"20","author":"Alidoost","year":"2019","journal-title":"Am. J. Case Rep."},{"issue":"12","key":"10.1016\/j.thromres.2021.05.018_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232769","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome presenting as bilateral adrenal infarction after knee arthroplasty","volume":"12","author":"VanderVeer","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.thromres.2021.05.018_bb0115","article-title":"Spontaneous heparin-induced thrombocytopenia syndrome presenting as cerebral venous sinus thrombosis","author":"Moores","year":"2020","journal-title":"Neurol. Clin. Pract."},{"issue":"11 Suppl. 1","key":"10.1016\/j.thromres.2021.05.018_bb0120","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/S0735-1097(20)33806-7","article-title":"Spontaneous heparin induced thrombocytopenia: when a post-op pulmonary embolism isn\u2019t just a post-op pulmonary embolism","volume":"75","author":"Hornick","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2021.05.018_bb0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.thromres.2020.08.009","article-title":"Spontaneous heparin induced thrombocytopenia (HIT) following curettage and bone graft of femur in a patient with monostotic fibrous dysplasia","volume":"196","author":"Swarup","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2021.05.018_bb0130","first-page":"1","article-title":"Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty","author":"Hwang","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2021.05.018_bb0135","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.artd.2021.03.005","article-title":"\u201cSpontaneous\u201d heparin-induced thrombocytopenia and thrombosis after total knee arthroplasty: a report of 2 cases","volume":"9","author":"Olevsky","year":"2021","journal-title":"J. Arthroplast."},{"issue":"5","key":"10.1016\/j.thromres.2021.05.018_bb0140","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1055\/s-0038-1648491","article-title":"Heparin-associated thrombocytopenia: the antibody is not heparin specific","volume":"67","author":"Greinacher","year":"1992","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-0038-1656329","article-title":"Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia","volume":"68","author":"Amiral","year":"1992","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI116987","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells","volume":"93","author":"Visentin","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.thromres.2021.05.018_bb0155","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2021.05.018_bb0160","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1182\/blood.V83.11.3232.3232","article-title":"Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4","volume":"83","author":"Kelton","year":"1994","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2021.05.018_bb0165","series-title":"Heparin-Induced Thrombocytopenia","first-page":"110","article-title":"Frequency of heparin-induced thrombocytopenia","author":"Linkins","year":"2013"},{"issue":"3","key":"10.1016\/j.thromres.2021.05.018_bb0170","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ajh.2830450312","article-title":"Pentosan polysulfate-induced thrombocytopenia and thrombosis","volume":"45","author":"Tardy-Poncet","year":"1994","journal-title":"Am. J. Hematol."},{"issue":"6 Pt 1","key":"10.1016\/j.thromres.2021.05.018_bb0175","first-page":"2148","article-title":"Pentosan induced cerebral sagittal sinus thrombosis: a variant of heparin-induced thrombocytopenia","volume":"160","author":"Rice","year":"1998","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.thromres.2021.05.018_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000233315","article-title":"Detection of antibodies interacting with glycosaminoglycan polysulfate in patients treated with heparin or other polysulfated glycosaminoglycans","volume":"70","author":"Wolf","year":"1983","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2021.05.018_bb0185","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2141.1992.tb08216.x","article-title":"Heparin-associated thrombocytopenia in a patient treated with polysulphated chondroitin sulphate: evidence for immunological crossreactivity between heparin and polysulphated glycosaminoglycan","volume":"81","author":"Greinacher","year":"1992","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.thromres.2021.05.018_bb0190","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMc081387","article-title":"Contaminated heparin","volume":"359","author":"Greinacher","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2021.05.018_bb0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/14740330902778180","article-title":"Anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes","volume":"8","author":"Warkentin","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.thromres.2021.05.018_bb0200","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/annonc\/mdf117","article-title":"Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia","volume":"13","author":"Rosenthal","year":"2002","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1067\/mlc.2001.115525","article-title":"Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia\/thrombosis","volume":"138","author":"Visentin","year":"2001","journal-title":"J. Lab. Clin. Med."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0210","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1538-7836.2009.03645.x","article-title":"The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia","volume":"8","author":"Warkentin","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2021.05.018_bb0215","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.thromres.2021.05.018_bb0220","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2010-08-301424","article-title":"Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia","volume":"117","author":"Krauel","year":"2011","journal-title":"Blood."},{"issue":"16","key":"10.1016\/j.thromres.2021.05.018_bb0225","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1182\/blood-2012-06-434985","article-title":"Platelet factor 4 binding of lipid A of Gram-negative bacteria exposes PF4\/heparin-like epitopes","volume":"120","author":"Krauel","year":"2012","journal-title":"Blood."},{"issue":"2","key":"10.1016\/j.thromres.2021.05.018_bb0230","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood-2013-01-478966","article-title":"Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4","volume":"122","author":"Jaax","year":"2013","journal-title":"Blood."},{"issue":"2","key":"10.1016\/j.thromres.2021.05.018_bb0235","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood-2013-05-504126","article-title":"HIT: nucleic acid masquerading as heparin","volume":"122","author":"Chong","year":"2013","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1160\/TH13-08-0634","article-title":"Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity","volume":"112","author":"Brandt","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0245","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1160\/TH15-01-0062","article-title":"Polyphosphates form antigenic complexes with platelet factor 4 (PF4) and enhance PF4-binding to bacteria","volume":"114","author":"Brandt","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0250","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/bloodadvances.2016000877","article-title":"Polyphosphate\/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia","volume":"1","author":"Cines","year":"2016","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0255","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/jth.13955","article-title":"Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and Fc\u03b3RIIa","volume":"16","author":"Palankar","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0260","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/jth.14012","article-title":"Bacterial killing by platelets: making sense of (H)IT","volume":"16","author":"Hoylaerts","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.05.018_bb0265","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.thromres.2017.09.018","article-title":"PF4-HIT antibody (KKO) complexes activate broad innate immune and inflammatory responses","volume":"159","author":"Haile","year":"2017","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0270","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.cell.2017.11.001","article-title":"Migrating platelets are mechano-scavengers that collect and bundle bacteria","volume":"171","author":"Gaertner","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0275","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1038\/s41467-020-19515-0","article-title":"Vascular surveillance by haptotactic blood platelets in inflammation and infection","volume":"11","author":"Nicolai","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.thromres.2021.05.018_bb0280","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1182\/blood-2011-03-342857","article-title":"Association of natural anti-platelet factor 4\/heparin antibodies with periodontal disease","volume":"118","author":"Greinacher","year":"2011","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0285","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.06-2109","article-title":"The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital","volume":"131","author":"Smythe","year":"2007","journal-title":"Chest."},{"issue":"20","key":"10.1016\/j.thromres.2021.05.018_bb0290","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.thromres.2021.05.018_bb0295","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/01.CIR.99.19.2530","article-title":"Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia","volume":"99","author":"Pouplard","year":"1999","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.thromres.2021.05.018_bb0300","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V96.5.1703","article-title":"Impact of the patient population on the risk for heparin-induced thrombocytopenia","volume":"96","author":"Warkentin","year":"2000","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0305","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1182\/blood-2013-11-540781","article-title":"B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia","volume":"123","author":"Zheng","year":"2014","journal-title":"Blood."},{"issue":"17","key":"10.1016\/j.thromres.2021.05.018_bb0310","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2013-01-477091","article-title":"Critical role for mouse marginal zone B cells in PF4\/heparin antibody production","volume":"121","author":"Zheng","year":"2013","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.thromres.2021.05.018_bb0315","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1373\/49.8.1286","article-title":"Time course of early and late changes in plasma DNA in trauma patients","volume":"49","author":"Lam","year":"2003","journal-title":"Clin. Chem."},{"issue":"20","key":"10.1016\/j.thromres.2021.05.018_bb0320","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1182\/blood-2008-08-173062","article-title":"The temporal profile of the anti-PF4\/heparin immune response","volume":"113","author":"Greinacher","year":"2009","journal-title":"Blood."},{"issue":"2","key":"10.1016\/j.thromres.2021.05.018_bb0325","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/blood-2008-10-186064","article-title":"Studies of the immune response in heparin-induced thrombocytopenia","volume":"113","author":"Warkentin","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2021.05.018_bb0330","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1160\/TH15-08-0654","article-title":"Further insights into the anti-PF4\/heparin IgM immune response","volume":"115","author":"Krauel","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2021.05.018_bb0335","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1182\/blood-2004-12-4955","article-title":"PF4\/heparin complexes are T-cell dependent antigens","volume":"106","author":"Suvarna","year":"2005","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.thromres.2021.05.018_bb0340","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1182\/blood-2014-09-603464","article-title":"Critical role of CD4 T cells in PF4\/heparin antibody production in mice","volume":"125","author":"Zheng","year":"2015","journal-title":"Blood."},{"issue":"7","key":"10.1016\/j.thromres.2021.05.018_bb0345","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.4049\/jimmunol.1900196","article-title":"Regulatory T cells control PF4\/heparin antibody production in mice","volume":"203","author":"Zheng","year":"2019","journal-title":"J. Immunol."},{"issue":"23","key":"10.1016\/j.thromres.2021.05.018_bb0350","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1182\/blood-2018-03-834598","article-title":"Polyreactive IgM initiates complement activation by PF4\/heparin complexes through the classical pathway","volume":"132","author":"Khandelwal","year":"2018","journal-title":"Blood."},{"issue":"14","key":"10.1016\/j.thromres.2021.05.018_bb0355","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood-2016-04-709634","article-title":"The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)","volume":"128","author":"Khandelwal","year":"2016","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.thromres.2021.05.018_bb0360","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2009-07-231506","article-title":"The severity of trauma determines the immune response to PF4\/heparin and the frequency of heparin-induced thrombocytopenia","volume":"115","author":"Lubenow","year":"2010","journal-title":"Blood."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0365","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jtcvs.2008.06.014","article-title":"Formation of anti-platelet factor 4\/heparin antibodies following cardiac surgery: influence of perioperative platelet activation, the inflammatory response, and histocompatibility leukocyte antigen status","volume":"136","author":"Paparella","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.thromres.2021.05.018_bb0370","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.athoracsur.2008.10.060","article-title":"Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required?","volume":"87","author":"Warkentin","year":"2009","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.thromres.2021.05.018_bb0375","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.thromres.2013.06.013","article-title":"Antiplatelet factor 4\/heparin antibodies in patients with gram negative bacteremia","volume":"132","author":"Pongas","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2021.05.018_bb0380","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.thromres.2018.09.060","article-title":"Anti-PF4\/heparin antibodies are increased in hospitalized patients with bacterial sepsis","volume":"171","author":"Maharaj","year":"2018","journal-title":"Thromb. Res."},{"issue":"9 Suppl","key":"10.1016\/j.thromres.2021.05.018_bb0385","doi-asserted-by":"crossref","first-page":"294S","DOI":"10.1177\/1076029618808915","article-title":"Profiling heparin-induced thrombocytopenia (HIT) antibodies in hospitalized patients with and without diabetes","volume":"24","author":"Prechel","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"10","key":"10.1016\/j.thromres.2021.05.018_bb0390","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jamasurg.2018.1652","article-title":"Association of heparin-induced thrombocytopenia with bacterial infection in trauma patients","volume":"153","author":"Grigorian","year":"2018","journal-title":"JAMA Surg."},{"key":"10.1016\/j.thromres.2021.05.018_bb0395","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s41100-016-0073-8","article-title":"A case of heparin-induced thrombocytopenia (HIT) triggered by methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia","volume":"2","author":"Sugioki","year":"2016","journal-title":"Adv. Ren. Replace. Ther."},{"issue":"9","key":"10.1016\/j.thromres.2021.05.018_bb0400","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3390\/diagnostics10090627","article-title":"Platelet-derived microparticles bearing PF4 and anti-GAGS immunoglobulins in patients with sepsis","volume":"10","author":"Sartori","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"10.1016\/j.thromres.2021.05.018_bb0405","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2021.05.018_bb0410","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-135-7-200110020-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia and thrombosis","volume":"135","author":"Warkentin","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.thromres.2021.05.018_bb0415","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-136-3-200202050-00009","article-title":"Delayed-onset heparin-induced thrombocytopenia","volume":"136","author":"Rice","year":"2002","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.thromres.2021.05.018_bb0420","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1056\/NEJMra1316259","article-title":"Ischemic limb gangrene with pulses","volume":"373","author":"Warkentin","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.thromres.2021.05.018_bb0425","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood-2017-06-788679","article-title":"Autoimmune HIT due to apheresis catheter heparin flushes for stem cell harvesting before autotransplantation for myeloma","volume":"130","author":"Mian","year":"2017","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.thromres.2021.05.018_bb0430","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood-2017-04-778993","article-title":"Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review","volume":"130","author":"Warkentin","year":"2017","journal-title":"Blood."},{"issue":"25","key":"10.1016\/j.thromres.2021.05.018_bb0435","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1056\/NEJMc070346","article-title":"Heparin-induced thrombocytopenia associated with fondaparinux","volume":"356","author":"Warkentin","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0440","first-page":"1319","article-title":"HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux-induced HIT","volume":"112","author":"Warkentin","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2021.05.018_bb0445","first-page":"394","article-title":"The serological profile of fondaparinux-associated heparin-induced thrombocytopenia syndrome","volume":"108","author":"Warkentin","year":"2012","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2021.05.018_bb0450","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1538-7836.2005.01560.x","article-title":"Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin","volume":"3","author":"Prechel","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.05.018_bb0455","doi-asserted-by":"crossref","first-page":"14945","DOI":"10.1038\/ncomms14945","article-title":"Anti-platelet factor 4\/polyanion antibodies mediate a new mechanism of autoimmunity","volume":"8","author":"Nguyen","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0460","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood-2014-06-580894","article-title":"Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis","volume":"125","author":"Padmanabhan","year":"2015","journal-title":"Blood."},{"issue":"10","key":"10.1016\/j.thromres.2021.05.018_bb0465","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.ATV.0000238350.89477.88","article-title":"Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies","volume":"26","author":"Greinacher","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"15","key":"10.1016\/j.thromres.2021.05.018_bb0470","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood-2014-03-559518","article-title":"Binding of anti-platelet factor 4\/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4","volume":"124","author":"Kreimann","year":"2014","journal-title":"Blood."},{"issue":"22","key":"10.1016\/j.thromres.2021.05.018_bb0475","doi-asserted-by":"crossref","first-page":"10130","DOI":"10.1039\/C5NR02132D","article-title":"Quantitative description of thermodynamic and kinetic properties of the platelet factor 4\/heparin bonds","volume":"7","author":"Nguyen","year":"2015","journal-title":"Nanoscale."},{"issue":"12","key":"10.1016\/j.thromres.2021.05.018_bb0480","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1021\/acsnano.8b04487","article-title":"Distinct binding characteristics of pathogenic anti-platelet factor-4\/polyanion antibodies to antigens coated on different substrates: a perspective on clinical application","volume":"12","author":"Nguyen","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.thromres.2021.05.018_bb0485","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.thromres.2021.05.018_bb0490","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1056\/NEJM200303133481120","article-title":"Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin","volume":"348","author":"Warkentin","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.thromres.2021.05.018_bb0495","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1160\/TH14-07-0593","article-title":"Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban","volume":"114","author":"Tardy-Poncet","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2021.05.018_bb0500","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1097\/00000542-199812000-00037","article-title":"Intraoperative heparin flushes and subsequent acute heparin-induced thrombocytopenia","volume":"89","author":"Ling","year":"1998","journal-title":"Anesthesiology."},{"issue":"22","key":"10.1016\/j.thromres.2021.05.018_bb0505","article-title":"IgG-class anti-PF4\/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics","volume":"12","author":"Motokawa","year":"2011","journal-title":"BMC Musculoskelet. Disord."},{"issue":"8","key":"10.1016\/j.thromres.2021.05.018_bb0510","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1182\/blood-2015-06-651620","article-title":"Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4\/heparin antibody formation after orthopedic surgery","volume":"127","author":"Bito","year":"2016","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5387\/fms.2018-06","article-title":"Induction of anti-PF4\/heparin antibodies after arthroplasty for rheumatic diseases","volume":"64","author":"Migita","year":"2018","journal-title":"Fukushima J. Med. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0520","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002247","article-title":"Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. A randomized controlled study","volume":"95","author":"Sakai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.thromres.2021.05.018_bb0525","series-title":"ECAT","first-page":"18","article-title":"4Ts score for the diagnosis of HIT","volume":"4","author":"Warkentin","year":"2014"},{"issue":"17","key":"10.1016\/j.thromres.2021.05.018_bb0530","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2106\/JBJS.N.01141","article-title":"Prevalence of total hip and knee replacement in the United States","volume":"97","author":"Kremers","year":"2015","journal-title":"J. Bone Joint Surg. Am."},{"issue":"4","key":"10.1016\/j.thromres.2021.05.018_bb0535","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/CCM.0b013e318206d0eb","article-title":"Bilateral adrenal hemorrhage: the unrecognized cause of hemodynamic collapse associated with heparin-induced thrombocytopenia","volume":"39","author":"Rosenberger","year":"2011","journal-title":"Crit. Care Med."},{"issue":"9","key":"10.1016\/j.thromres.2021.05.018_bb0540","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3899\/jrheum.170990","article-title":"Rates of total joint replacement in the United States: future projections to 2020-2040 using the national inpatient sample","volume":"46","author":"Singh","year":"2019","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.thromres.2021.05.018_bb0545","series-title":"Heparin-induced Thrombocytopenia","first-page":"24","article-title":"Clinical picture of heparin-induced thrombocytopenia","author":"Warkentin","year":"2013"},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0550","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12028-009-9320-y","article-title":"Heparin-induced thrombocytopenia and cerebral venous sinus thrombosis: case report and literature review","volume":"15","author":"Fesler","year":"2011","journal-title":"Neurocrit. Care."},{"issue":"5","key":"10.1016\/j.thromres.2021.05.018_bb0555","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1160\/TH07-06-0423","article-title":"Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: a consequence of heparin \u201cflushes\u201d","volume":"98","author":"Refaai","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2021.05.018_bb0560","first-page":"958","article-title":"Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation","volume":"94","author":"Warkentin","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2021.05.018_bb0565","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1517\/14740338.2013.823946","article-title":"Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls","volume":"13","author":"Warkentin","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.thromres.2021.05.018_bb0570","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/blood-2016-01-635003","article-title":"How I treat patients with a history of heparin-induced thrombocytopenia","volume":"128","author":"Warkentin","year":"2016","journal-title":"Blood."},{"issue":"22","key":"10.1016\/j.thromres.2021.05.018_bb0575","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa2104840","article-title":"Prothrombotic thrombocytopenia following ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.thromres.2021.05.018_bb0580","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 CoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.thromres.2021.05.018_bb0585","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 CoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.thromres.2021.05.018_bb0590","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.thromres.2021.05.018_bb0595","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMc2106075","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination\u2014response from the manufacturer","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2021.05.018_bb0600","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced thrombotic thrombocytopenia","author":"Bourguignon","year":"2021","journal-title":"N. Engl. J. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821003571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821003571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:45:21Z","timestamp":1758735921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384821003571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":120,"alternative-id":["S0049384821003571"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2021.05.018","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2021.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}